All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Molecular Partners AG revenue reports

Molecular Partners AG financial reports, Molecular Partners AG annual revenue in 2024. When does Molecular Partners AG report revenue?
Add to widgets
Added to widgets

Molecular Partners AG total revenue, net income and dynamics of changes in Swiss franc today

Molecular Partners AG revenue for the past few reporting periods. The dynamics of Molecular Partners AG net revenue has changed by 63 000 Fr over the last period. The dynamics of Molecular Partners AG net income rose by 2 454 000 Fr. The assessment of the dynamics of Molecular Partners AG net income was made in comparison with the previous report. The financial schedule of Molecular Partners AG consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The financial report chart on our website displays information by dates from 31/03/2019 to 31/03/2021. The value of all Molecular Partners AG assets on the graph is shown in green.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 977 000 Fr -74.323 % ↓ -16 554 000 Fr -
31/12/2020 914 000 Fr -73.31 % ↓ -19 008 000 Fr -
30/09/2020 914 000 Fr -73.31 % ↓ -19 008 000 Fr -
31/03/2020 3 805 000 Fr - -13 345 000 Fr -
31/12/2019 3 424 500 Fr - -12 028 000 Fr -
30/09/2019 3 424 500 Fr - -12 028 000 Fr -
30/06/2019 6 775 500 Fr - -6 372 000 Fr -
31/03/2019 6 775 500 Fr - -6 372 000 Fr -
Show:
to

Molecular Partners AG financial report charts

The latest dates of Molecular Partners AG financial statements available online: 31/03/2019, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of Molecular Partners AG is available online for such a date - 31/03/2021. Gross profit Molecular Partners AG is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Molecular Partners AG is -15 186 000 Fr

Molecular Partners AG quarterly report dates

Cost of revenue Molecular Partners AG is the total cost of producing and distributing of products and services of a company. Cost of revenue Molecular Partners AG is 16 163 000 Fr Total revenue Molecular Partners AG refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Molecular Partners AG is 977 000 Fr Operating income Molecular Partners AG is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Molecular Partners AG is -18 530 000 Fr

Net income Molecular Partners AG is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Molecular Partners AG is -16 554 000 Fr Current assets Molecular Partners AG is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Molecular Partners AG is 163 801 000 Fr Total assets Molecular Partners AG refers to the total amount of assets owned by a person or entity. Total assets Molecular Partners AG is 173 035 000 Fr

31/03/2021 31/12/2020 30/09/2020 31/03/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-15 186 000 Fr -14 553 000 Fr -14 553 000 Fr -9 558 000 Fr -9 079 500 Fr -9 079 500 Fr -2 720 500 Fr -2 720 500 Fr
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
16 163 000 Fr 15 467 000 Fr 15 467 000 Fr 13 363 000 Fr 12 504 000 Fr 12 504 000 Fr 9 496 000 Fr 9 496 000 Fr
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
977 000 Fr 914 000 Fr 914 000 Fr 3 805 000 Fr 3 424 500 Fr 3 424 500 Fr 6 775 500 Fr 6 775 500 Fr
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 3 424 500 Fr 3 424 500 Fr 6 775 500 Fr 6 775 500 Fr
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-18 530 000 Fr -17 617 000 Fr -17 617 000 Fr -12 220 000 Fr -12 349 500 Fr -12 349 500 Fr -6 200 500 Fr -6 200 500 Fr
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-16 554 000 Fr -19 008 000 Fr -19 008 000 Fr -13 345 000 Fr -12 028 000 Fr -12 028 000 Fr -6 372 000 Fr -6 372 000 Fr
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - - - 9 496 000 Fr 9 496 000 Fr
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
19 507 000 Fr 18 531 000 Fr 18 531 000 Fr 16 025 000 Fr 15 774 000 Fr 15 774 000 Fr 12 976 000 Fr 12 976 000 Fr
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
163 801 000 Fr 177 812 000 Fr 177 812 000 Fr 68 519 000 Fr 99 900 000 Fr 99 900 000 Fr 129 487 000 Fr 129 487 000 Fr
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
173 035 000 Fr 187 546 000 Fr 187 546 000 Fr 73 330 000 Fr 104 960 000 Fr 104 960 000 Fr 134 882 000 Fr 134 882 000 Fr
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
106 171 000 Fr 133 721 000 Fr 133 721 000 Fr 47 318 000 Fr 95 100 000 Fr 95 100 000 Fr 67 625 000 Fr 67 625 000 Fr
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 29 100 000 Fr 29 100 000 Fr 34 544 000 Fr 34 544 000 Fr
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 51 360 000 Fr 51 360 000 Fr 56 817 000 Fr 56 817 000 Fr
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 48.93 % 48.93 % 42.12 % 42.12 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
94 758 000 Fr 107 220 000 Fr 107 220 000 Fr 54 139 000 Fr 53 600 000 Fr 53 600 000 Fr 78 065 000 Fr 78 065 000 Fr
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -14 119 000 Fr -14 119 000 Fr 13 519 000 Fr 13 519 000 Fr

Last revenue report of Molecular Partners AG was 31/03/2021. According to last financial report total revenue in Molecular Partners AG was 977 000 Swiss franc and changed by -74.323% since last year. Net income in Molecular Partners AG was -16 554 000 Fr in last quartal, net income changes to 0%.

Current cash Molecular Partners AG - the sum of all of the cash a company has on the date of report. Current cash Molecular Partners AG is 106 171 000 Fr

Molecular Partners AG stocks data

Molecular Partners AG financials